References
- Mukherjee, P.K., Mukherjee, D., Maji, A.K., Rai, S., Heinrich, M. The sacred lotus (Nelumbo nucifera)—phytochemical and therapeutic profile. J. Pharm. Pharmacol. 2009, 61, 407–422.
- Mukherjee, P.K., Das, J., Balasubramanian, R., Saha, K., Pal, M., Saha, B.P. Antidiarrhoeal evaluation of Nelumbo nucifera rhizome extract. Ind. J. Exp. Biol. 1995a, 27, 262–264.
- Mukherjee, P.K., Pal, S.R., Saha, K., Saha, B.P. Hypoglycemic activity of Nelumbo nucifera rhizome (methanolic extract) in streptozotocin induced diabetic rats. Phytother. Res. 1995b, 9, 522–524.
- Mukherjee, P.K., Saha, K., Balasubramanian, R., Pal, M., Saha, B.P. Studies on psychopharmacological effects of Nelumbo nucifera Gaertn. rhizome extract. J. Ethnopharmacol. 1996, 54, 63–67.
- Mukherjee, P.K., Saha, K., Das, J., Pal, M., Saha, B.P. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med. 1997, 63, 367–369.
- Sinha, S., Mukherjee, P.K., Mukherjee, K., Pal, M., Mandal, S.C., Saha, B.P. Evaluation of antipyretic potential of Nelumbo nucifera stalk extract. Phytother. Res. 2000, 14, 272–274.
- Blanco-Colio, L.M., Tuñón, J., Martín-Ventura, J.L., Egido, J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 2003, 63, 12–23.
- Cheng, W., Li, J., You, T., Hu, C. Anti-inflammatory and immunomodulatory activities of the extracts from the inflorescence of Chrysanthemum indicum Linné. J. Ethnopharmacol. 2005, 101, 334–337.
- Galli, S.J., Grimbaldeston, M., Tsai, M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8, 478–486.
- Baumann, H., Gauldie, J. The acute phase response. Immunol. Today 1994, 15, 74–80.
- Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman, A.S., Morimoto, C., Nadler, L.M.B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 6575–6579.
- Chen, C., Gault, A., Shen, L., Nabavi, N. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule. J. Immunol. 1994, 152, 4929–4936.
- Mukherjee P.K. (2002). Quality Control of Herbal Drugs—An Approach to Evaluation of Botanicals ( pp. 246–370). Business Horizons, New Delhi, India.
- Shinde, U.A., Phadke, A.S., Nair, A.M., Mungantiwar, A.A., Dikshit, V.J., Saraf, V.O. Membrane stabilizing activity—a possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil. Fitoterapia. 1999,70, 251–257.
- Norton, S. Quantitative determination of mast cell fragmentation by compound 48/80. Br. J. Pharmacol. Chemother. 1954, 9, 494–497.
- Ray, A., Chattopadhyay, K., Banerjee, K.K., Biswas, T. Macrophage distinguishes Vibrio cholerae hemolysin from its protease insensitive oligomer by time dependent and selective expression of CD80-CD86. Immunol. Lett. 2003, 89, 143–147.
- Ding, A.H., Nathan, C.F., Stuehr, D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988, 141, 2407–2412.
- Ferrali, M., Signorini, C., Ciccoli, L., Comporti, M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem. J. 1992, 285 (Pt 1), 295–301.
- Maxwell, S.R.J. Prospects for the use of anti-oxidant therapies. Drugs. 1995, 49, 345–361.
- Liu, G.T., Zhang, T.M., Wang, B.E., Wang, Y.W. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem. Pharmacol. 1992, 43, 147–152.
- Aitadafoun, M., Mounieri, C., Heyman, S.F., Binistic, C., Bon, C., Godhold, J. 4-Alkoxybenzamides as new potent phosholipase A2 inhibitors. Biochem. Pharmacol. 1996, 51, 737–742.
- Yun, Y., Han, S., Park, E., Yim, D., Lee, S., Lee, C.K., Cho, K., Kim K. Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Arch. Pharm. Res. 2003, 26, 1087–1095.
- Leifeld, L., Trautwein, C., Dumoulin, F.L., Manns, M.P., Sauerbruch, T., Spengler, U. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am. J. Pathol. 1999, 154, 1711–1720.
- Odobasic, D., Kitching, A.R., Semple, T.J., Timoshanko, J.R., Tipping, P.G., Holdsworth, S.R. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2005, 16, 2012–2022.
- Kawagishi, C., Kurosaka, K., Watanabe, N., Kobayashi, Y. Cytokine production by macrophages in association with phagocytosis of etoposide-treated P388 cells in vitro and in vivo. Biochim. Biophys. Acta 2001, 1541, 221–230.
- Rajapakse, N., Kim, M.M., Mendis, E., Kim, S.K. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling. Immunology. 2008, 123, 348–357.
- Coleman, J.W. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 2001, 1, 1397–1406.